In this episode of Decisions Now, host Erin Pearson speaks with Aleksandar Ruzic about how value-based healthcare, patient-centric design, and data science are reshaping commercial strategies in life sciences. Aleks shares powerful real-world examples from rare diseases, obesity treatments, and global market launches, revealing how integrating value metrics into R&D, regulatory planning, and go-to-market execution leads to smarter decisions and sustainable growth. Subscribe now to stay ahead of emerging trends in healthcare and beyond. 

Ver todos los episodios